To further provide evidence that the mechanism of CKI treatment in BC was related to the VEGF signaling pathway, we carried out molecular docking experiments between the active components of CKI and the targets (PIK3CA, SRC, and NOS3) involved in the VEGF signaling pathway. Here, NOS3 is linked to breast cancer.